FDA
-
-
-
-
-
-
-
Fennec Pharmaceuticals to Report First Quarter 2026 Financial Results on May 14, 2026
-
-
-
-
-
-
-
Fennec Pharmaceuticals Announces Investigator-Sponsored Trial to Be Conducted by City of Hope in Metastatic Testicular Germ Cell Tumors
-
-
-
-
-
-
-
Fennec Pharmaceuticals Announces Closing of Offering of Common Shares
-
-
-
-
-
-
-
Fennec Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Fennec Pharmaceuticals Announces Commercial Launch of PEDMARQSI® In Germany
-
-
-
-
-
-
-
Fennec Pharmaceuticals Strengthens Executive Leadership Team with Three Key Appointments to Accelerate the Company’s Next Stage of Growth
-
-
-
-
-
-
-
Fennec Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
-
328,433 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

